Researchers Angelika Mühlebner

Angelika Mühlebner

Associate Professor - medical

Strategic program(s):

Biography

Medical University Vienna, Vienna, Austria	MD	31-07-2008	medicine
Medical University Vienna, Vienna, Austria		31-08-2009	neuropathology residency
University Hospital Erlangen, Erlangen, Germany	PhD	12-05-2012	epilepsy-associated pathology
Medical University Vienna, Vienna, Austria		31-03-2014	pediatrics residency
Amsterdam Medical Center, AMC, Amsterdam, The Netherlands		31-12-2015	postdoctoral researcher
Amsterdam Medical Center, AMS, Amsterdam, The Netherlands		30-09-2020	pathology residency
University Medical Center Utrecht, Utrecht, The Netherlands	Associate professor	21-12-2021	fellowship neuropathology
University Medical Center Utrecht, Utrecht, The Netherlands		ongoing	neuropathology, head of cytology unit

Strategic program(s):

Contact

amuhleb2@umcutrecht.nl

Pure profile

Research groups

Neuropathology

Research aim

Our aim is to drive and improve state-of-the-art diagnostics, enhance knowlegde and advance targeted interventions for individuals affected by neurological disorders.

Go to group

Recent publications

All publications

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification Natalie Berghaus, Arnault Tauziède-Espariat, Thomas Hielscher, Dilan Savran, Daniel Schrimpf, Kirsten Göbel, Eric Stutheit-Zhao, Lukas Friedrich, Felix Keller, Fuat Kaan Aras, Filippo Nozzoli, Dominik Sturm, Christine L White, Simone Schmid, Christian Mawrin, Julia E Neumann, Till Acker, Rudi Beschorner, Christian Hartmann, Irem Saribiyik, Arda Inan, Ayça Erşen-Danyeli, Mariëtte E G Kranendonk, Sybren L N Maas, Eelke M Bos, Eleonora Aronica, Saskia M Peerdeman, Nikki B Thuijs, Angelika Mühlebner, Benno Kusters, Wilfred F A den Dunnen, Cinzia E Lavarino, Stéphanie Puget, Jason Chiang, Sonika Dahiya, Melike Pekmezci, Arie Perry, Oluwadamilola Akanji, Miriam Ratliff, Christel Herold-Mende, Sandro M Krieg, Wolfgang Wick, Stefan M Pfister, Pieter Wesseling, Andreas von Deimling, Pascale Varlet, Felix Sahm, Philipp Sievers
Nature Communications, 2026, vol. 17

Exploring brain-glioma interaction Eva A Krijnen, Emma van Kessel, Angelika Mühlebner, Sven van Kempen, Wim Van Hecke, Martine J E van Zandvoort, Pierre A Robe, Tom J Snijders
Neuro-oncology advances, 2026, vol. 8

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS) Josephus L M van Rooij, Peter H Wessels, Johanna M Niers, Jacoline E C Bromberg, Johanna M M Gijtenbeek, Rick van Haastert, Henk J T Ruven, Bob Meek, Marcel M Verbeek, Nienke Solleveld-Westerink, Wendy W J de Leng, Angelika Mühlebner, Anton W Langerak, Sharon Berendsen, Edward F Knol, Hanna van Alkemade, Tatjana Seute, Monique C Minnema, Stefan Nierkens, Tom J Snijders
The Lancet. Haematology, 2026, vol. 13, p.e376-e385

Associations of cognitive and behavioural impairment in ALS with brain pathology Hanneke M J Slaghekke, Rosanne Govaarts, Lucia Mesarosova, Angelika Mühlebner, Emma Beeldman, Marianne de Visser, Michael A van Es, Leonard H van den Berg, Anneke J van der Kooi, Yolande A L Pijnenburg, Eleonora Aronica, Joost Raaphorst
Journal of Neurology, 2026, vol. 273

Many roads lead to Rome Katja Kobow, Angelika Mühlebner
Clinical Epileptology, 2026, vol. 39, p.84-90

TSC-associated microglial hyperactivity Rozemarijn S Kalf, Mark J Luinenburg, Giulia Dematteis, Mirte Scheper, Jasper J Anink, Giulia Cavallo, Andrea Mattarei, Wim Van Hecke, Angelika Mühlebner, Laura Tapella, James D Mills, Dmitry Lim, Eleonora Aronica
Acta Neuropathologica, 2026, vol. 151